BML Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-248,702
Closed -$460K 32
2024
Q3
$460K Buy
248,702
+205,959
+482% +$381K 0.27% 24
2024
Q2
$370K Hold
42,743
0.26% 27
2024
Q1
$374K Hold
42,743
0.25% 29
2023
Q4
$318K Buy
+42,743
New +$318K 0.24% 31